Northwest Biotherapeutics (NWBO) Prepaid Assets (2010 - 2026)

Northwest Biotherapeutics' Prepaid Assets history runs 17 years deep, the most recent figure standing at $4.4 million for Q1 2026.

• In Q1 2026, Prepaid Assets rose 131.57% year-over-year to $4.4 million; the TTM figure through Mar 2026 stood at $4.4 million (up 131.57% YoY), while the FY2025 annual figure was $2.2 million, up 14.79% from the prior year.
• Prepaid Assets for Q1 2026 stood at $4.4 million, up from $2.2 million in the prior quarter.
• The five-year high for Prepaid Assets was $4.4 million in Q1 2026, with the low at $1.7 million in Q3 2023.
• The 5-year median for Prepaid Assets is $2.3 million (2022), against an average of $2.4 million.
• The sharpest annual moves came in 2022 and 2026: Prepaid Assets plunged 59.89% in 2022, then soared 131.57% in 2026.
• Northwest Biotherapeutics' Prepaid Assets stood at $2.5 million in 2022, then retreated by 18.74% to $2.0 million in 2023, then decreased by 5.6% to $1.9 million in 2024, then advanced by 14.79% to $2.2 million in 2025, then soared by 103.88% to $4.4 million in 2026.
• Business Quant data shows NWBO's Prepaid Assets at $4.4 million in Q1 2026, $2.2 million in Q4 2025, and $2.3 million in Q3 2025.